ClinicalTrials.govpublic full text
A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.
cancer, neoplasm, cancer vaccine, ny-eso-1b peptide, cpg 7909, montanide® isa-51, lage-1, immune response, safety, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 839717
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.